RecruitingNot ApplicableNCT05845021

Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty

The Impact of a Surgeon-Initiated Bone Health Referral Pathway on Implant-Related Complications in Patients With Osteoporosis Undergoing Lower Extremity Arthroplasty


Sponsor

Johns Hopkins University

Enrollment

2,000 participants

Start Date

Sep 27, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to observe the impact of a surgeon-driven bone health referral pathway following lower extremity arthroplasty. The main question this study aims to answer is: 1\) What is impact of a surgeon-driven bone health referral pathway on implant-related complications and fragility fractures when compared to standard of care primary care provider referral. Researchers will compare the endocrinology referral pathway and standard of care to see if there is a difference in treatment rates, fragility fractures, and implant-related complications following lower extremity arthroplasty.


Eligibility

Min Age: 50 Years

Inclusion Criteria2

  • \>50
  • DEXA-confirmed diagnosis of osteoporosis

Exclusion Criteria2

  • Prior diagnosis of osteoporosis
  • Prior treatment for osteoporosis

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTSurgeon-Initiated Bone Health Referral Pathway

Described in arm description


Locations(1)

Charter Professional Center

Columbia, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05845021


Related Trials